280 related articles for article (PubMed ID: 23212832)
1. Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR).
Gleicher N; Kim A; Weghofer A; Shohat-Tal A; Lazzaroni E; Lee HJ; Barad DH
J Assist Reprod Genet; 2013 Jan; 30(1):49-62. PubMed ID: 23212832
[TBL] [Abstract][Full Text] [Related]
2. Hypoandrogenism in association with diminished functional ovarian reserve.
Gleicher N; Kim A; Weghofer A; Kushnir VA; Shohat-Tal A; Lazzaroni E; Lee HJ; Barad DH
Hum Reprod; 2013 Apr; 28(4):1084-91. PubMed ID: 23427231
[TBL] [Abstract][Full Text] [Related]
3. The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women.
Hu Q; Hong L; Nie M; Wang Q; Fang Y; Dai Y; Zhai Y; Wang S; Yin C; Yang X
J Ovarian Res; 2017 May; 10(1):32. PubMed ID: 28472976
[TBL] [Abstract][Full Text] [Related]
4. The impact of androgen metabolism and FMR1 genotypes on pregnancy potential in women with dehydroepiandrosterone (DHEA) supplementation.
Weghofer A; Kim A; Barad DH; Gleicher N
Hum Reprod; 2012 Nov; 27(11):3287-93. PubMed ID: 22811313
[TBL] [Abstract][Full Text] [Related]
5. Dehydroepiandrosterone plus climen supplementation shows better effects than dehydroepiandrosterone alone on infertility patients with diminished ovarian reserve of low-FSH level undergoing in-vitro fertilization cycles: a randomized controlled trial.
Zhang H; Chu Y; Zhou P; He X; Xu Q; Zhang Z; Cao Y; Wei Z
Reprod Biol Endocrinol; 2016 Feb; 14():9. PubMed ID: 26879683
[TBL] [Abstract][Full Text] [Related]
6. Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?
Kara M; Aydin T; Aran T; Turktekin N; Ozdemir B
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():63-5. PubMed ID: 24331115
[TBL] [Abstract][Full Text] [Related]
7. Toward a better understanding of functional ovarian reserve: AMH (AMHo) and FSH (FSHo) hormone ratios per retrieved oocyte.
Gleicher N; Kim A; Weghofer A; Barad DH
J Clin Endocrinol Metab; 2012 Mar; 97(3):995-1004. PubMed ID: 22170712
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of combined FSH and AMH observations in infertile women.
Gleicher N; Kim A; Kushnir V; Weghofer A; Shohat-Tal A; Lazzaroni E; Lee HJ; Barad DH
J Clin Endocrinol Metab; 2013 May; 98(5):2136-45. PubMed ID: 23533225
[TBL] [Abstract][Full Text] [Related]
9. A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.
Yeung TW; Chai J; Li RH; Lee VC; Ho PC; Ng EH
Fertil Steril; 2014 Jul; 102(1):108-115.e1. PubMed ID: 24796766
[TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.
Yilmaz N; Uygur D; Inal H; Gorkem U; Cicek N; Mollamahmutoglu L
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):257-60. PubMed ID: 23664458
[TBL] [Abstract][Full Text] [Related]
11. Novel dehydroepiandrosterone troche supplementation improves the serum androgen profile of women undergoing in vitro fertilization.
Keane KN; Hinchliffe PM; Namdar N; Conceicao JL; Newsholme P; Yovich JL
Drug Des Devel Ther; 2015; 9():5569-78. PubMed ID: 26487801
[TBL] [Abstract][Full Text] [Related]
12. Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation.
Gleicher N; Weghofer A; Barad DH
Reprod Biomed Online; 2010 Sep; 21(3):360-5. PubMed ID: 20638339
[TBL] [Abstract][Full Text] [Related]
13. Dehydroepiandrosterone supplementation increases baseline follicular phase progesterone levels.
Weissman A; Horowitz E; Ravhon A; Golan A; Levran D
Gynecol Endocrinol; 2011 Dec; 27(12):1014-7. PubMed ID: 21500990
[TBL] [Abstract][Full Text] [Related]
14. Effect of chronological age of patients with diminished ovarian reserve on
Li S; Hu L; Zhang C
J Obstet Gynaecol; 2022 May; 42(4):654-657. PubMed ID: 34384322
[TBL] [Abstract][Full Text] [Related]
15. Dehydroepiandrosterone administration before IVF in poor responders: a prospective cohort study.
Vlahos N; Papalouka M; Triantafyllidou O; Vlachos A; Vakas P; Grimbizis G; Creatsas G; Zikopoulos K
Reprod Biomed Online; 2015 Feb; 30(2):191-6. PubMed ID: 25498594
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Dehydroepiandrosterone (DHEA) to overcome the effect of ovarian ageing (DITTO): A proof of principle double blinded randomized placebo controlled trial.
Narkwichean A; Maalouf W; Baumgarten M; Polanski L; Raine-Fenning N; Campbell B; Jayaprakasan K
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():39-48. PubMed ID: 28934714
[TBL] [Abstract][Full Text] [Related]
17. A prospective study on role of dehydroepiandrosterone (DHEA) on improving the ovarian reserve markers in infertile patients with poor ovarian reserve.
Singh N; Zangmo R; Kumar S; Roy KK; Sharma JB; Malhotra N; Vanamail P
Gynecol Endocrinol; 2013 Nov; 29(11):989-92. PubMed ID: 24004296
[TBL] [Abstract][Full Text] [Related]
18. Association of basal serum androgen levels with ovarian response and ICSI cycle outcome.
Abide Yayla C; Ozkaya E; Kayatas Eser S; Sanverdi I; Devranoglu B; Kutlu T
Ir J Med Sci; 2018 May; 187(2):409-415. PubMed ID: 28744698
[TBL] [Abstract][Full Text] [Related]
19. Diminished ovarian reserve is not observed in infertility patients with high normal CGG repeats on the fragile X mental retardation 1 (FMR1) gene.
Schufreider A; McQueen DB; Lee SM; Allon R; Uhler ML; Davie J; Feinberg EC
Hum Reprod; 2015 Nov; 30(11):2686-92. PubMed ID: 26345686
[TBL] [Abstract][Full Text] [Related]
20. A double-blind randomised controlled trial on the effect of dehydroepiandrosterone on ovarian reserve markers, ovarian response and number of oocytes in anticipated normal ovarian responders.
Yeung T; Chai J; Li R; Lee V; Ho PC; Ng E
BJOG; 2016 Jun; 123(7):1097-105. PubMed ID: 26663817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]